Glucose Health, Inc. (GLUC) appointed John Duffy as CEO effective September 1, 2026, succeeding Mark Schaftlein. No financial targets, operating updates, or guidance changes were provided, so near-term market impact is likely limited.
Glucose Health, Inc. (GLUC) appointed John Duffy as CEO effective September 1, 2026, succeeding Mark Schaftlein. No financial targets, operating updates, or guidance changes were provided, so near-term market impact is likely limited.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
